Coronavirus

Moderna Confirms Its COVID-19 Vaccine Could Be Industry's Most Expensive

Executives from the Cambridge-based company discussed the commercialization plans for its vaccine and other business updates on Wednesday

NBCUniversal, Inc.

Local biotech firm Moderna Inc. has indicated its COVID-19 vaccine could be one of the most expensive in the industry.

Executives from the Cambridge-based company discussed the commercialization plans for its COVID-19 vaccine, mRNA-1273, and other business updates during the company's second quarter earnings call Wednesday.

There were four key takeaways from the call.

Read more at the Boston Business Journal.

Contact Us